Addressing Unanswered Questions in the Treatment of Atherosclerosis: Atorv astatin Global Investigators Meeting 2000BRUNTON, Stephen.The American journal of cardiology. 2001, Vol 88, Num 7B, issn 0002-9149, 56 p.Conference Proceedings

Women and cardiovascular riskWELTY, Francine K.The American journal of cardiology. 2001, Vol 88, Num 7B, pp 48J-52J, issn 0002-9149Conference Paper

Global risk assessment in the presymptomatic patientDEEDWANIA, Prakash.The American journal of cardiology. 2001, Vol 88, Num 7B, pp 17J-22J, issn 0002-9149Conference Paper

Insulin resistance syndrome and type 2 diabetes mellitusERKELENS, D. Willem.The American journal of cardiology. 2001, Vol 88, Num 7B, pp 38J-42J, issn 0002-9149Conference Paper

What have we learned about the biology of atherosclerosis ? The role of inflammationLIBBY, Peter.The American journal of cardiology. 2001, Vol 88, Num 7B, pp 3J-6J, issn 0002-9149Conference Paper

Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial diseaseCRIQUI, Michael H.The American journal of cardiology. 2001, Vol 88, Num 7B, pp 43J-47J, issn 0002-9149Conference Paper

The use of electron-beam computed tomography as a tool for primary preventionRAGGI, Paolo.The American journal of cardiology. 2001, Vol 88, Num 7B, pp 28J-32J, issn 0002-9149Conference Paper

What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes ?WATERS, David D; HSUE, Priscilla Y.The American journal of cardiology. 2001, Vol 88, Num 7B, pp 7J-16J, issn 0002-9149Conference Paper

United States cholesterol guidelines 2001 : Expanded scope of intensive low-density lipoprotein-lowering therapyGRUNDY, Scott M.The American journal of cardiology. 2001, Vol 88, Num 7B, pp 23J-27J, issn 0002-9149Conference Paper

Cerebrovascular disease and statins : A potential addition to the therapeutic armamentarium for Stroke PreventionCALLAHAN, Alfred.The American journal of cardiology. 2001, Vol 88, Num 7B, pp 33J-37J, issn 0002-9149Conference Paper